<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01119989</url>
  </required_header>
  <id_info>
    <org_study_id>protocole 51/10</org_study_id>
    <nct_id>NCT01119989</nct_id>
  </id_info>
  <brief_title>Effects of an Amino-acid Supplement on Hepatic Lipid Metabolism</brief_title>
  <acronym>AMINOFRUCT</acronym>
  <official_title>Effects of a Supplementation With Amino-acids on Hepatic Lipid Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      10 healthy male volunteers will be studied after&#xD;
&#xD;
        -  a 6 day weight maintenance, balanced diet&#xD;
&#xD;
        -  a 6 days weight maintenance, balanced diet supplemented with 3 grams fructose/kg body&#xD;
           weight/day&#xD;
&#xD;
        -  a 6 days weight maintenance, balanced diet supplemented with 3 grams fructose/kg body&#xD;
           weight/day and 20g amino-acids per day At the end of each 6 days period, the following&#xD;
           measurements will be obtained&#xD;
&#xD;
        -  intrahepatic lipids (1H-MRS)&#xD;
&#xD;
        -  metabolic effects of fructose ingestion (measurement of substrate oxidation,&#xD;
           gluconeogenesis from fructose, palmitate synthesis from fructose, plasma VLDL-kinetics)&#xD;
&#xD;
      This is a randomized, double blinded study&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intrahepatic lipids</measure>
    <time_frame>after 6 days on each controlled diet</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>13C palmitate synthesis</measure>
    <time_frame>after 6 days on each controlled diet</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>weight maintenance diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>weight maintenance + fructose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>weight maintenance diet + fructose and amino-acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose+maltodextrin placebo</intervention_name>
    <arm_group_label>weight maintenance + fructose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>amino-acid + fructose</intervention_name>
    <arm_group_label>weight maintenance diet + fructose and amino-acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-30 years&#xD;
&#xD;
          -  sex: males&#xD;
&#xD;
          -  BMI between 19 and 25 kg/m2&#xD;
&#xD;
          -  less than 3 30min- exercise session/week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smokers&#xD;
&#xD;
          -  alcohol consumption more than 50g/week&#xD;
&#xD;
          -  consumption of drugs&#xD;
&#xD;
          -  history of diabetes in first degree relatives&#xD;
&#xD;
          -  presence of ferro-magnetic prosthesis, cardiac pacemakers, or any contra-indication to&#xD;
             NMR&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>VD</state>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 6, 2010</study_first_submitted>
  <study_first_submitted_qc>May 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2010</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Luc Tappy, MD</investigator_full_name>
    <investigator_title>Professor of Physiology</investigator_title>
  </responsible_party>
  <keyword>hepatic fat content</keyword>
  <keyword>hepatic de novo lipogenesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

